1. Israel Stocks

  2. •

    Industrials

  3. •

    Conglomerates
Aran Research & Development (1982) Ltd.

Aran Research & Development (1982) Ltd.

ARAN.TA
Aran Research & Development (1982) Ltd.IL flagTel Aviv Stock Exchange
4,150.00
ILA
-40.00
- -
187.67MMarket Cap
Aran Research & Development (1982) Ltd.
ARAN.TA
(Tel Aviv Stock Exchange)

Recent

price

4,150.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
21.38
18.66
23.56
19.56
29.08
28.19
23.38
19.65
41.91
35.37
35.19
44.62
- -
20.45
Revenue per Share
3.59
0.22
0.78
0.87
1.32
1.86
0.48
0.62
2.24
4.81
3.29
1.4
- -
0.64
Basic EPS, GAAP
-3.88
-1.62
1.2
-1.06
4.34
-3.31
0.51
5.13
-5.14
-11.24
-0.2
7.3
- -
- -
Free Cash Flow per Basic Share
1
0.5
0.5
0.5
1.41
0.2
0.87
- -
0.61
0.61
1.23
- -
- -
- -
Dividend per Share
- -
5.92
5.46
5.42
4.72
4.75
4.68
4.6
4.61
4.59
4.6
4.63
- -
4.79
Book Value per Share
- -
10.96
10.12
10.18
9.46
10.53
10.09
10.97
12.87
17.98
18.09
19.9
- -
11.42
Tangible Book Value per Share
4
5
5
5
5
5
5
5
5
5
5
5
- -
5
Basic Weighted Avg Shares
95
84
115
95
142
138
114
96
205
173
172
218
263
96
Sales/Revenue/Turnover
36.15
4.14
2.05
-0.63
2.58
5.05
0.3
2.68
5.95
4.32
-2.38
4.35
6.06
2.68
Operating Margin (%)
2
2
3
3
3
3
6
6
6
4
5
8
8
- -
Depreciation Expense
16
1
4
4
6
9
2
3
11
23
16
7
19
3
Net Income, GAAP
25.57
28.79
12.29
5.28
15.93
16.03
- -
13.41
20.6
28.28
15.17
22.94
22.5
13.41
Effective Tax Rate (%)
16.77
1.21
3.32
4.43
4.55
6.58
2.04
3.14
5.34
13.6
9.36
3.13
7.09
3.14
Profit Margin (%)
- -
19
22
24
22
22
19
27
55
75
76
84
80
27
Working Capital
- -
- -
9
8
7
6
13
15
57
72
33
19
16
15
LT Debt
- -
54
55
55
53
60
58
60
68
89
102
109
105
60
Total Equity
- -
7.5
3.02
-0.81
4.56
8.24
- -
2.58
7.93
3.13
-1.91
4.58
8.94
2.58
Return on Invested Capital (%)
- -
-3.66
10.3
13.13
17.01
25.34
- -
7.53
14.7
16.53
14.13
9.41
21.47
7.53
Return on Capital (%)
- -
7.6
14.29
15.96
26.13
39.19
10.12
13.27
48.63
104.47
71.64
30.24
93.32
13.27
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'20
Sep'20
Dec'20
ST Debt
17
- -
17
LT Borrowings
9
- -
8
LT Finance Leases
7
- -
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
5
Market Capitalization
4,864
6,141
8,479

Working Capital

FRC

•

in mil. unless spec.
Jun'20
Sep'20
Dec'20
Total Current Assets
65
- -
100
Cash, Cash Equivalents & STI
27
- -
50
Accounts Receivable, Net
25
- -
30
Inventories
4
- -
3
Total Current Liabilities
37
- -
74
Payables & Accruals
- -
- -
- -
ST Debt
17
- -
17
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.22%
12.31%
-3.21%
Free Cash Flow
-386.43%
-756.6%
59.99%
Net Income, GAAP
52.21%
92.65%
174.16%
Sales/Revenue/Turnover
14.09%
28.96%
20.81%
Total Cash Common Dividend
- -
- -
134%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
172
2024
- -
- -
- -
- -
218
2025
- -
- -
- -
- -
263

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
3.29
2024
- -
- -
- -
- -
1.4
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.23
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Doosan Corporation (000155.KS)
CJ Corporation (001040.KS)
Thoresen Thai Agencies Public Company Limited (TTA-R.BK)
Sojitz Corporation (SZHFF)
Kanematsu Corporation (8020.T)
CK Hutchison Holdings Limited (CKHUY)
Business
Aran Research & Development (1982) Ltd. (ARAN.TA) is an Israel-based product design, development and manufacturing firm that specializes in high-tech solutions across medical devices, water and fluid management systems, defense and homeland security technologies, consumer and industrial products, and equipment for the plastics industry. Founded in 1982 and headquartered in Caesarea, the company provides comprehensive product development services including industrial design, mechanical and electronics engineering, rapid prototyping via 3D printing and CNC machining, and full-scale production; it develops medical devices such as cardiovascular interventional systems, in-vitro diagnostics, surgical instruments, imaging and monitoring equipment; water devices encompassing pressure and flow regulators, electric and hydraulic valves, air release valves, sprinklers, drippers, taps, water meters, filters, check valves, electronic controllers and testing devices; defense products like portable and stationary control stations for unmanned systems, electro-optics, rugged electronics for ground, marine and aerial platforms, access control systems, test equipment and production facilities; consumer and industrial offerings including measurement and weighing devices, specialty printers, automatic beverage machines, computerized shopping carts, self-checkout kiosks, industrial communication devices and batteries; and plastics industry equipment such as injection molding machines from ENGEL, robotics and automation from ENGEL and STAR, injection molds, hot runner systems from YUDO and HEITEC, drying, dosing and conveying systems from PIOVAN, plasticizing screws and barrels, ultrasonic welding and cleaning systems, plus raw materials from EXXON MOBIL and CABOT. Aran operates primarily in Israel with a focus on domestic and international markets in these sectors, serving clients from startups to multinational corporations, and maintains investments in medical startups including ongoing projects like the GoBack Catheter from Upstream Peripheral Technologies and Endoaid Ltd. for gastrointestinal endoscopy. In recent developments, the company continues to leverage its expertise in 3D printing and advanced manufacturing, as demonstrated by its support for student engineering projects and community initiatives in robotics and Formula SAE racing components, while sustaining its role as an exclusive agent for global plastics equipment leaders amid steady operations on the Tel Aviv Stock Exchange.